Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors

NCT06775236 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Breast Cancer

Interventions

DRUG: SYS6010 jnjection
DRUG: monotherapy chemotherapy
DRUG: SYH2051 tablets

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.